Skip to main content
Fig. 5 | BMC Microbiology

Fig. 5

From: Intra-wound vancomycin powder for the eradication of periprosthetic joint infection after debridement and implant exchange: experimental study in a rat model

Fig. 5

Histopathological assessment of the distal femur on days 28, with magnification (6× and 20×). Control (no antibiotics); SV: Systemic vancomycin (intraperitoneal injection, 88 mg/kg, every 12 h); VP: Intra-wound vancomycin powder (before closure of the capsule, 88 mg/kg, single dosage); SV&VP: Systemic vancomycin & intra-wound VP (intraperitoneal injection, 88 mg/kg, every 12 h; combined with intra-wound VP before closure of the capsule, 88 mg/kg, single dosage). n = 5

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us